75
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Classification and coding of platelet-rich plasma derived from New Zealand white rabbits for tissue engineering and regenerative medicine applications

ORCID Icon, , , , , , , & show all
Pages 1473-1482 | Received 25 Feb 2021, Accepted 09 Jul 2021, Published online: 27 Jul 2021

References

  • Oryan A, Alidadi S, Moshiri A. Platelet-rich plasma for bone healing and regeneration. Expert Opin Biol Ther. 2016;16(2):213–232.
  • Wu PI, Diaz R, Borg-Stein J. Platelet-Rich plasma. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):825–853.
  • Sampson S, Gerhardt M, Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2008 Dec;1(3–4):165–174.
  • Özgürtaş T, Utku B, Yildiz C. Platelet-Rich plasma. In: Korkusuz F, editor. Musculoskeletal research and basic science. Cham: Springer; 2016. p. 283–288.
  • Sharun K, Pawde AM. Platelet-rich plasma for hip osteoarthritis: comparing the variables in production protocol and composition. Clin Rheumatol. 2020a Dec;39(12):3899–3901.
  • Sharun K, Pawde AM. Variables affecting the potential efficacy of platelet-rich plasma in dermatology. J Am Acad Dermatol. 2021a Jan;84(1):e47–e48.
  • Sharun K, Pawde AM; Amarpal. Classification and coding systems for platelet-rich plasma (PRP): a peek into the history. Expert Opin Biol Ther. 2021 Feb;21(2):121–123.
  • Sharun K, Pawde AM. Letter to the editor: histopathological evaluation of the effects of intraurethral platelet rich plasma in urethral trauma experimentally induced in rat model. Urology. 2020b Oct;144:267.
  • Sharun K, Pawde AM. Letter regarding: the effects of platelet-rich plasma to decrease the risk of seroma formation after mastectomy and axillary dissection. J Surg Res. 2021b Feb;258:467–468.
  • Lapi S, Nocchi F, Lamanna R, et al. Different media and supplements modulate the clonogenic and expansion properties of rabbit bone marrow mesenchymal stem cells. BMC Res Notes. 2008 Jul 28;1(1):53.
  • Cacchioli A, Spaggiari B, Ravanetti F, et al. The critical sized bone defect: morphological study of bone healing. Ann Fac Medic Vet Di Parma. 2006;26:97–110.
  • Sandeep G, Varma HK, Kumary TV, et al. Characterization of novel bioactive glass coated hydroxyapatite granules in correlation with in vitro and in vivo studies. Trends Biomater Artif Organs. 2006;19:99–107.
  • Magalon J, Bausset O, Serratrice N, et al. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 2014 May;30(5):629–638.
  • Yin W, Xu H, Sheng J, et al. Optimization of pure platelet-rich plasma preparation: a comparative study of pure platelet-rich plasma obtained using different centrifugal conditions in a single-donor model. Exp Ther Med. 2017 Sep;14(3):2060–2070.
  • Harrison P. Subcommittee on platelet physiology. The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(9):1895–1900.
  • Kon E, Di Matteo B, Delgado D, et al. Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system. Expert Opin Biol Ther. 2020;20(12):1447-1460.
  • Fielder SE. Hematologic reference ranges - MSD veterinary manual. 2015; [cited 2021 Feb 20]. Available from: https://www.msdvetmanual.com/special-subjects/reference-guides/hematologic-reference-ranges
  • Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol. 2009 Mar;27(3):158–167.
  • Mishra A, Harmon K, Woodall J, et al. Sports medicine applications of platelet rich plasma. Curr Pharm Biotechnol. 2012 Jun;13(7):1185–1195.
  • DeLong JM, Russell RP, Mazzocca AD. Platelet-rich plasma: the PAW classification system. Arthroscopy. 2012 Jul;28(7):998–1009.
  • Cervelli V, Palla L, Pascali M, et al. Autologous platelet-rich plasma mixed with purified fat graft in aesthetic plastic surgery. Aesthetic Plast Surg. 2009 Sep;33(5):716–721.
  • Gentile P, Orlandi A, Scioli MG, et al. A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med. 2012 Apr;1(4):341–351.
  • Gentile P, Garcovich S. Systematic review: adipose-derived mesenchymal stem cells, platelet-rich plasma and biomaterials as new regenerative strategies in chronic skin wounds and soft tissue defects. Int J Mol Sci. 2021 Feb 3;22(4):1538.
  • Cervelli V, Lucarini L, Spallone D, et al. Use of platelet-rich plasma and hyaluronic acid in the loss of substance with bone exposure. Adv Skin Wound Care. 2011 Apr;24(4):176–181.
  • Gentile P, Di Pasquali C, Bocchini I, et al. Breast reconstruction with autologous fat graft mixed with platelet-rich plasma. Surg Innov. 2013 Aug;20(4):370–376.
  • Cervelli V, Bocchini I, Di Pasquali C, et al. P.R.L. platelet rich lipotransfert: our experience and current state of art in the combined use of fat and PRP. Biomed Res Int. 2013;2013:434191.
  • Gentile P, De Angelis B, Pasin M, et al. Adipose-derived stromal vascular fraction cells and platelet-rich plasma: basic and clinical evaluation for cell-based therapies in patients with scars on the face. J Craniofac Surg. 2014 Jan;25(1):267–272.
  • Gentile P, Bottini DJ, Spallone D, et al. Application of platelet-rich plasma in maxillofacial surgery: clinical evaluation. J Craniofac Surg. 2010 May;21(3):900–904.
  • Scioli MG, Bielli A, Gentile P, et al. Combined treatment with platelet-rich plasma and insulin favours chondrogenic and osteogenic differentiation of human adipose-derived stem cells in three-dimensional collagen scaffolds. J Tissue Eng Regen Med. 2017 Aug;11(8):2398–2410.
  • Malhotra A, Pelletier MH, Yu Y, et al. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg. 2013 Feb;133(2):153–165.
  • Kanthan SR, Kavitha G, Addi S, et al. Platelet-rich plasma (PRP) enhances bone healing in non-united critical-sized defects: a preliminary study involving rabbit models. Injury. 2011 Aug;42(8):782–789.
  • Guzel Y, Karalezli N, Bilge O, et al. The biomechanical and histological effects of platelet-rich plasma on fracture healing. Knee Surg Sports Traumatol Arthrosc. 2015 May;23(5):1378–1383.
  • Gentile P, Scioli MG, Bielli A, et al. Platelet-Rich plasma and micrografts enriched with autologous human follicle mesenchymal stem cells improve hair re-growth in androgenetic alopecia. Biomolecular pathway analysis and clinical evaluation. Biomedicines. 2019 Apr 8;7(2):27.
  • Cervelli V, Garcovich S, Bielli A, et al. The effect of autologous activated platelet rich plasma (AA-PRP) injection on pattern hair loss: clinical and histomorphometric evaluation. Biomed Res Int. 2014;2014:760709.
  • Gentile P, Garcovich S, Bielli A, et al. The effect of platelet-rich plasma in hair regrowth: a randomized placebo-controlled trial. Stem Cells Transl Med. 2015 Nov;4(11):1317–1323.
  • Gentile P, Cole JP, Cole MA, et al. Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and Cytokine concentrations obtained by different collection systems. Int J Mol Sci. 2017 Feb 14;18(2):408.
  • Gentile P, Garcovich S, Scioli MG, et al. Mechanical and controlled PRP injections in patients affected by androgenetic alopecia. J Vis Exp. 2018 Jan;27(131):56406.
  • Gentile P, Garcovich S. Autologous activated platelet-rich plasma (AA-PRP) and non-activated (A-PRP) in hair growth: a retrospective, blinded, randomized evaluation in androgenetic alopecia. Expert Opin Biol Ther. 2020 Mar;20(3):327–337.
  • Gentile P, Calabrese C, De Angelis B, et al. Impact of the different preparation methods to obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in plastic surgery: wound healing and hair regrowth evaluation. Int J Mol Sci. 2020 Jan 9;21(2):431.
  • Gentile P, Scioli MG, Bielli A, et al. Concise review: the use of adipose-derived stromal vascular fraction cells and platelet rich plasma in regenerative plastic surgery. Stem Cells. 2017 Jan;35(1):117–134.
  • Gentile P, Garcovich S. Systematic review-the potential implications of different Platelet-Rich Plasma (PRP) concentrations in regenerative medicine for tissue repair. Int J Mol Sci. 2020 Aug 9;21(16):5702.
  • Appel TR, Pötzsch B, Müller J, et al. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin Oral Implants Res. 2002 Oct;13(5):522–528.
  • Mautner K, Malanga GA, Smith J, et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R. 2015;7(4 Suppl):S53–S59.
  • Chahla J, Cinque ME, Piuzzi NS, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg Am. 2017 Oct 18;99(20):1769–1779.
  • Dohan Ehrenfest DM, Andia I, Zumstein MA, et al. Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J. 2014 May 8;4(1):3–9.
  • Murray IR, Chahla J, Safran MR, et al. Cell therapies communication expert group. international expert consensus on a cell therapy communication tool: DOSES. J Bone Joint Surg Am. 2019 May 15;101(10):904–911.
  • Andia I, Maffulli N. Some patients (and some of us) respond better to some biological therapies: the as yet unsolved conundrum. J Orthop Traumatol. 2018 Aug 20;19(1):1.
  • Andia I, Maffulli N. Blood-Derived products for tissue repair/regeneration. Int J Mol Sci. 2019 Sep 17;20(18):4581.
  • Andia I, Perez-Valle A, Del Amo C, et al. Freeze-Drying of platelet-rich plasma: the quest for standardization. Int J Mol Sci. 2020 Sep 20;21(18):6904.
  • Andia I, Maffulli N. A contemporary view of platelet-rich plasma therapies: moving toward refined clinical protocols and precise indications. Regen Med. 2018 Sep;13(6):717–728.
  • Pignatelli P, Pulcinelli FM, Ciatti F, et al. Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation. J Clin Lab Anal. 1995;9(2):138–140.
  • White JG. EDTA-induced changes in platelet structure and function: clot retraction. Platelets. 2000 Feb;11(1):49–55.
  • Scherer SS, Tobalem M, Vigato E, et al. Nonactivated versus thrombin-activated platelets on wound healing and fibroblast-to-myofibroblast differentiation in vivo and in vitro. Plast Reconstr Surg. 2012 Jan;129(1):46e–54e.
  • Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10(4):225–228.
  • Wang SZ, Fan WM, Jia J, et al. Is exclusion of leukocytes from platelet-rich plasma (PRP) a better choice for early intervertebral disc regeneration? Stem Cell Res Ther. 2018 Jul 18;9(1):199.
  • Zhang L, Chen S, Chang P, et al. Harmful effects of leukocyte-rich platelet-rich plasma on rabbit tendon stem cells in vitro. Am J Sports Med. 2016 Aug;44(8):1941–1951.
  • Kobayashi Y, Saita Y, Nishio H, et al. Leukocyte concentration and composition in platelet-rich plasma (PRP) influences the growth factor and protease concentrations. J Orthop Sci. 2016 Sep;21(5):683–689.
  • Weibrich G, Gnoth SH, Otto M, et al. Wachstumsstimulation von humanen osteoblastenähnlichen Zellen durch Thrombozytenkonzentrate in vitro [Growth stimulation of human osteoblast-like cells by thrombocyte concentrates in vitro]. Mund Kiefer Gesichtschir. 2002 May 6;6(3):168–174. German.
  • Ghaffarpasand F, Dehghankhalili M, Shahrezaei M. Platelet rich plasma for traumatic non-union fractures: a novel butcontroversial bone regeneration strategy. Bull Emerg Trauma. 2013 Jul;1(3):99–101.
  • Giusti I, Rughetti A, D’Ascenzo S, et al. Identification of an optimal concentration of platelet gel for promoting angiogenesis in human endothelial cells. Transfusion. 2009 Apr;49(4):771–778.
  • Magalon J, Chateau AL, Bertrand B, et al. DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices. BMJ Open Sport Exerc Med. 2016 Feb 4;2(1):e000060.
  • Mautner K, Malanga GA, Smith J, et al. A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R. 2015;7(4 Suppl):S53–S59.
  • Lana JFSD, Purita J, Paulus C, et al. Contributions for classification of platelet rich plasma - proposal of a new classification: MARSPILL. Regen Med. 2017 Jul; 12(5):565–574.
  • Aydın A, Sönmez MG, Oltulu P, et al. Histopathologic evaluation of the effects of intraurethral platelet rich plasma in urethral trauma experimentally induced in rat model. Urology. 2020 Jul;141:187.e9–187.e14.
  • Shapiro J, Ho A, Sukhdeo K, et al. Evaluation of platelet-rich plasma as a treatment for androgenetic alopecia: a randomized controlled trial. J Am Acad Dermatol. 2020 Nov;83(5):1298–1303.
  • Sharun K, Pawde AM, Pal A. Platelet-rich plasma (PRP) for skin graft enrichment: the need for a universal PRP classification system. Int Wound J. 2020 Dec;17(6):2038–2039.
  • Svigos K, Yin L, Shaw K, et al. Use of platelet-rich plasma in lichen planopilaris and its variants: a retrospective case series demonstrating treatment tolerability without koebnerization. J Am Acad Dermatol. 2020 Nov;83(5):1506–1509.
  • Pawar M, Singh M. Microneedling with autologous platelet-rich plasma versus microneedling with topical insulin in the treatment of postacne atrophic scars: a simultaneous split-face comparative study. J Am Acad Dermatol. 2021 Mar;84(3):810–811.
  • Magalon J, Abellan-Lopez M, Brandin T, et al. Response to universal classification system for Platelet-Rich Plasma (PRP): a method to define the variables in PRP production. Burns. 2021 Mar;47(2):489–490.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.